Erratum to: HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia (Q57767266)
Jump to navigation
Jump to search
scholarly article published 17 March 2014 in Stem Cells
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erratum to: HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia |
scholarly article published 17 March 2014 in Stem Cells |
Statements
Erratum to: HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia (English)
0 references
17 March 2014
0 references
32
0 references
4
0 references
1056-1056
0 references